Insiders · Profile

Zalevsky Jonathan

Chief R&D Officer at NEKTAR THERAPEUTICS. Filing since 18 Nov 2019. CIK 0001789857

Company

Date

Role

Action

Shares

Amount

Of holding

NKTR NEKTAR THERAPEUTICS

18 Aug 2026

Chief R&D Officer

Sold at will

186

$13.39K

1.9%

NKTR NEKTAR THERAPEUTICS

30 Jun 2026

Chief R&D Officer

Sold on a plan

5,681

$397.67K

36.8%

NKTR NEKTAR THERAPEUTICS

15 Jun 2026

Chief R&D Officer

Sold on a plan

5,538

$336.21K

26.4%

NKTR NEKTAR THERAPEUTICS

19 May 2026

Chief R&D Officer

Sold at will

199

$13.04K

0.9%

NKTR NEKTAR THERAPEUTICS

18 Feb 2026

Chief R&D Officer

Sold at will

180

$13.14K

0.8%

NKTR NEKTAR THERAPEUTICS

20 Jan 2026

Chief R&D Officer

Sold on a plan

3,867

$137.94K

15.3%

NKTR NEKTAR THERAPEUTICS

25 Nov 2025

Chief R&D Officer

Sold at will

1,157

$62.80K

5.7%

NKTR NEKTAR THERAPEUTICS

4 Sep 2025

Chief R&D Officer

Sold on a plan

1,721

$57.69K

9.0%

NKTR NEKTAR THERAPEUTICS

2 Sep 2025

Chief R&D Officer

Sold on a plan

485

$14.60K

2.5%

NKTR NEKTAR THERAPEUTICS

19 Aug 2025

Chief R&D Officer

Sold at will

725

$19.28K

3.6%

NKTR NEKTAR THERAPEUTICS

19 May 2025

Chief R&D Officer

Sold at will

10,712

$7.18K

3.4%

NKTR NEKTAR THERAPEUTICS

19 Feb 2025

Chief R&D Officer

Sold at will

10,300

$10.40K

3.2%

NKTR NEKTAR THERAPEUTICS

19 Dec 2024

Chief R&D Officer

Sold at will

51,115

$48.05K

13.5%

NKTR NEKTAR THERAPEUTICS

19 Nov 2024

Chief R&D Officer

Sold at will

7,785

$7.86K

3.1%

NKTR NEKTAR THERAPEUTICS

19 Aug 2024

Chief R&D Officer

Sold at will

6,866

$8.79K

2.7%

NKTR NEKTAR THERAPEUTICS

17 May 2024

Chief R&D Officer

Sold at will

7,355

$12.87K

2.8%

NKTR NEKTAR THERAPEUTICS

20 Feb 2024

Chief R&D Officer

Sold at will

9,014

$6.13K

3.3%

NKTR NEKTAR THERAPEUTICS

17 Nov 2023

Chief R&D Officer

Sold at will

9,646

$4.73K

3.4%

NKTR NEKTAR THERAPEUTICS

16 Aug 2023

Chief R&D Officer

Sold at will

9,703

$7.57K

3.3%

NKTR NEKTAR THERAPEUTICS

16 May 2023

Chief R&D Officer

Sold at will

9,791

$7.05K

3.2%

NKTR NEKTAR THERAPEUTICS

16 Feb 2023

Chief R&D Officer

Sold, plan not stated

10,484

$31.45K

3.3%

NKTR NEKTAR THERAPEUTICS

16 Nov 2022

Chief R&D Officer

Sold, plan not stated

13,460

$48.05K

4.1%

NKTR NEKTAR THERAPEUTICS

18 Aug 2022

Chief R&D Officer

Sold, plan not stated

73,716

$342.78K

18.4%

NKTR NEKTAR THERAPEUTICS

16 Aug 2022

Chief R&D Officer

Sold, plan not stated

10,560

$50.27K

2.6%

NKTR NEKTAR THERAPEUTICS

16 May 2022

Chief R&D Officer

Sold, plan not stated

21,673

$85.61K

7.3%

NKTR NEKTAR THERAPEUTICS

16 Feb 2022

Chief R&D Officer

Sold, plan not stated

10,912

$119.49K

3.8%

NKTR NEKTAR THERAPEUTICS

16 Nov 2021

Chief R&D Officer

Sold, plan not stated

20,869

$274.64K

8.3%

NKTR NEKTAR THERAPEUTICS

16 Aug 2021

Chief R&D Officer

Sold, plan not stated

7,662

$105.97K

3.5%

NKTR NEKTAR THERAPEUTICS

17 May 2021

Chief R&D Officer

Sold, plan not stated

31,111

$569.33K

11.7%

NKTR NEKTAR THERAPEUTICS

16 Feb 2021

Chief R&D Officer

Sold, plan not stated

24,141

$540.03K

8.3%

NKTR NEKTAR THERAPEUTICS

23 Nov 2020

Chief R&D Officer

Sold, plan not stated

16,380

$268.63K

6.1%

NKTR NEKTAR THERAPEUTICS

16 Nov 2020

Chief R&D Officer

Sold, plan not stated

29,618

$501.43K

10.0%

NKTR NEKTAR THERAPEUTICS

17 Aug 2020

Chief R&D Officer

Sold, plan not stated

26,200

$515.35K

8.1%

NKTR NEKTAR THERAPEUTICS

18 May 2020

Chief R&D Officer

Sold, plan not stated

4,558

$102.60K

1.4%

NKTR NEKTAR THERAPEUTICS

18 Feb 2020

Chief R&D Officer

Sold, plan not stated

4,774

$106.70K

1.4%

NKTR NEKTAR THERAPEUTICS

18 Nov 2019

Chief R&D Officer

Sold, plan not stated

3,960

$71.16K

1.3%

36 decisions on file.